top of page

Video Channels

FEATURED VIDEOS

What is Ocular Melanoma?

Uveal Melanoma with Liver Metastases: Patient Experience, Treatment Challenges & Hope on the Horizon

TriSalus Life Sciences
Uveal Melanoma with Liver Metastases: Patient Experience, Treatment Challenges & Hope on the Horizon
Uveal Melanoma with Liver Metastases: Patient Experience, Treatment Challenges & Hope on the Horizon
04:53

Uveal Melanoma with Liver Metastases: Patient Experience, Treatment Challenges & Hope on the Horizon

TriSalus Life Sciences
Uveal Melanoma 2022 | C. Shields
38:47

Uveal Melanoma 2022 | C. Shields

Νοσοκομείο Υγεία
Uveal Melanoma, A Modern Approach to Ocular Oncology | Tara McCannel, MD | UCLAMDChat
28:43

Uveal Melanoma, A Modern Approach to Ocular Oncology | Tara McCannel, MD | UCLAMDChat

UCLA Health
Choroidal Melanoma
09:27

Choroidal Melanoma

Moran CORE
Ocular Melanoma - See Your Eye Professional Today
02:44

Ocular Melanoma - See Your Eye Professional Today

Ocular Melanoma Foundation
Meeting at the office
Meeting at the office
FEATURED CHANNELS
Meeting at the office

Can cancer treatment impact my eyes and vision?

Many cancer treatments can affect your eyes and vision in a variety of ways. Some mild eye-related side effects, such as dryness or blurred vision, can resolve on their own, but serious side effects can impact your vision in the long term.

112024 Cancer Today.jpg
What is mUM Kimmtrak.jpg
Meeting at the office
American Society of Retina Specialists banner.png

American Society of Retina Specialists

Multiple, Successive Branch Retinal Artery Occlusions in a Patient with Antiphospholipid Syndrome

American Society of Retina Specialists
Multiple, Successive Branch Retinal Artery Occlusions in a Patient with Antiphospholipid Syndrome
Multiple, Successive Branch Retinal Artery Occlusions in a Patient with Antiphospholipid Syndrome
12:30

Multiple, Successive Branch Retinal Artery Occlusions in a Patient with Antiphospholipid Syndrome

American Society of Retina Specialists
Clinical Characteristics and Outcome of Delayed Diagnosis of Intraocular Foreign Bodies
10:41

Clinical Characteristics and Outcome of Delayed Diagnosis of Intraocular Foreign Bodies

American Society of Retina Specialists
IOI, Safety Events and Outcomes After Intravitreal Anti-VEGF Injections for nAMD
10:54

IOI, Safety Events and Outcomes After Intravitreal Anti-VEGF Injections for nAMD

American Society of Retina Specialists
Meeting at the office
The Eye Cancer Foundation banner.jpg

The mission of The Eye Cancer Foundation is three-fold: to develop and encourage international, multi-center research on new diagnostic treatments; to provide much-needed support services for patients and their families; and to save lives through our international fellowship program by training doctors in underserved and unserved countries.

It has been our goal to create a world-class resource for patients and their families diagnosed with eye cancer in the form of ocular tumors, macular degeneration, and related ophthalmic conditions. We want to help you, your children and families around the world. 

The Eye Cancer Foundation

2023 ISOO Fellow Presentations: Day 3

The Eye Cancer Foundation
2023 ISOO Fellow Presentations: Day 3
2023 ISOO Fellow Presentations: Day 3
20:16

2023 ISOO Fellow Presentations: Day 3

The Eye Cancer Foundation
2023 ISOO Fellow Presentations: Day 2
17:33

2023 ISOO Fellow Presentations: Day 2

The Eye Cancer Foundation
2023 ISOO Fellow Presentations: Day 1
34:30

2023 ISOO Fellow Presentations: Day 1

The Eye Cancer Foundation
Meeting at the office
Tara McCannel banner.jpg

Finding Your Way With Ocular Melanoma

Why Your Voice Matters: How Patients (Not Doctors) Move the Needle in MedicalProgress

Finding Your Way With Ocular Melanoma
Why Your Voice Matters: How Patients (Not Doctors) Move the Needle in MedicalProgress
Why Your Voice Matters: How Patients (Not Doctors) Move the Needle in MedicalProgress
15:28

Why Your Voice Matters: How Patients (Not Doctors) Move the Needle in MedicalProgress

Finding Your Way With Ocular Melanoma
Dr. Tara and Dr. Hsinyi Discuss Preventive Benefits of Blending East & Western Medicine
06:38

Dr. Tara and Dr. Hsinyi Discuss Preventive Benefits of Blending East & Western Medicine

Finding Your Way With Ocular Melanoma
Dr.Tara and Dr.Hsinyi demonstrate Self-Acupressure for Pain Relief
02:40

Dr.Tara and Dr.Hsinyi demonstrate Self-Acupressure for Pain Relief

Finding Your Way With Ocular Melanoma
Tara McCannel webinar event info.png
Meeting at the office
Melanoma Research Alliance logo blk bkg.png
The Melanoma Research Alliance

Advancing Discoveries,

Changing Lives, Curing Melanoma.

MRA is the world’s largest private nonprofit funder of melanoma research.

We’ve directly invested over $175 million toward scientific discoveries,

and we won’t stop until we achieve our mission of curing melanoma.

MelanomaReAlli

MRA Meet Up: Oncolytic Immunotherapy, Clinical Trials, & the Emerging RP1 Treatment

MelanomaReAlli
MRA Meet Up: Oncolytic Immunotherapy, Clinical Trials, & the Emerging RP1 Treatment
MRA Meet Up: Oncolytic Immunotherapy, Clinical Trials, & the Emerging RP1 Treatment
46:17

MRA Meet Up: Oncolytic Immunotherapy, Clinical Trials, & the Emerging RP1 Treatment

MelanomaReAlli
What Does Melanoma Research Mean to You?
02:41

What Does Melanoma Research Mean to You?

MelanomaReAlli
Melanoma: Know the Facts, Rare Subtypes, and What's New in Research
01:02:52

Melanoma: Know the Facts, Rare Subtypes, and What's New in Research

MelanomaReAlli
Meeting at the office
Melanoma Research Foundation logo.png
Melanoma Research Foundation Banner.jpg
CURE OM (the Community United for Research and Education of Ocular Melanoma) is the MRF’s initiative to increase awareness, education and research funding for ocular melanoma, while improving the lives of people affected by this disease. Founded in 2011, the CURE OM initiative excels because of the hard work and dedication of its Patient and Scientific Steering Committees and the generosity of our community.
Melanoma Research Foundation Ocular Melanoma Fact Sheet image.jpg
Melanoma Research Foundation Ask A Nurse image.jpg

Cure Melanoma

2025 MRF Denver Gala Courage Award

Cure Melanoma
2025 MRF Denver Gala Courage Award
2025 MRF Denver Gala Courage Award
09:53

2025 MRF Denver Gala Courage Award

Cure Melanoma
Lindsay and Paul Zubeck Welcome Everyone to the 14th Annual Denver Gala
01:00

Lindsay and Paul Zubeck Welcome Everyone to the 14th Annual Denver Gala

Cure Melanoma
Ask The Expert: 2025 ASCO Highlights for the Ocular Melanoma Community
59:38

Ask The Expert: 2025 ASCO Highlights for the Ocular Melanoma Community

Cure Melanoma
Meeting at the office
Nord banner.jpg
Nord EVENT Rare Disease Scientific Symposium banner.png
Nord logo.png

Ocular Melanoma

Last updated: 8/20/2024
Years published: 2018, 2024

Full Report Link @ https://rarediseases.org/rare-diseases/ocular-melanoma/

Acknowledgment

NORD gratefully acknowledges Gioconda Alyea, MD (FMG), MS, National Organization for Rare Disorders, Prithvi Mruthyunjaya, MD, MHS, Associate Professor of Ophthalmology, Ocular Oncology and Vitreoretinal Surgery; Director, Ocular Oncology Service, Byers Eye Institute at Stanford, and the Ocular Melanoma Foundation, for assistance in the preparation of this report.

Disease Overview

Summary

Ocular melanoma is an extremely rare type of cancer that occurs in about 5 out of every million adults. Despite its rarity, it is the most common primary cancer of the eye in adults. A primary cancer means that the cancer begins in the eye itself and has not spread there from another part of the body. The exact cause of ocular melanoma is unknown, but several risk factors have been identified, including genetic factors and possibly environmental influences. Despite this uncertainty, early detection and treatment are crucial for the best outcomes.

Introduction

Eye (ocular) cancer can refer to any cancer that starts in the eye.

The eye is a complex organ with three main parts:

  1. Eyeball (globe): The main part of the eye, filled with a jelly-like substance called vitreous humor. It has three layers:

    • Sclera: The tough, white outer layer

    • Uvea: The middle layer, responsible for nourishment and containing the eye’s pigmented cells

    • Retina: The innermost layer, which senses light and is crucial for vision

  2. Orbit: The tissues surrounding the eyeball

  3. Adnexal structures: These include accessory parts like the eyelids and tear glands

Different types of cancer can develop in these areas depending on the type of cells involved. Ocular melanoma typically arises from cells called melanocytes, which produce pigment. When these melanocytes in the choroid become cancerous, the condition is known as choroidal or uveal melanoma. Although these melanocytes are similar to those in the skin, skin melanoma and ocular melanoma are distinct conditions, each with different biological and genetic characteristics. It is rare for skin melanoma to spread to the eye or vice versa.

Uveal melanomas

Ocular melanoma can start at the uveal tract, the colored layer of tissue beneath the white of the eye (sclera). The uvea consists of three parts:

  1. Iris: The colored part of the eye which surrounds the pupil

  2. Ciliary body: A ring of muscle tissue that releases aqueous humor (a clear fluid) and helps control the lens’s shape for focusing

  3. Choroid: The largest part of the uveal tract, located at the back of the eye beneath the retina. This area is rich in blood vessels and pigmented cells.

Most ocular melanomas develop in the choroid or ciliary body. About 9 out of 10 intraocular melanomas occur in these areas. Iris melanomas are less common and usually easier to detect because they often start as a dark spot on the iris that grows over time. Iris melanomas are generally slow-growing and rarely spread, leading to a relatively good prognosis.

Uveal melanomas can spread through the bloodstream, most often reaching the liver, where the cancer can become life-threatening.

 

Conjunctival melanomas

The conjunctiva is a thin, clear layer covering the sclera. Conjunctival melanomas are extremely rare but tend to be more aggressive. They can grow into nearby structures and spread through both the blood and lymphatic systems, reaching distant organs like the lungs, liver or brain.

Full Report Link @ https://rarediseases.org/rare-diseases/ocular-melanoma/

National Organization for Rare Disorders (NORD)

Leveraging Innovative Trial Designs and Technologies to Accelerate - NORD Scientific Symposium

National Organization for Rare Disorders (NORD)
Leveraging Innovative Trial Designs and Technologies to Accelerate - NORD Scientific Symposium
Leveraging Innovative Trial Designs and Technologies to Accelerate - NORD Scientific Symposium
56:21

Leveraging Innovative Trial Designs and Technologies to Accelerate - NORD Scientific Symposium

National Organization for Rare Disorders (NORD)
What’s Next in Rare Disease Data Collection and Clinical Use - NORD Scientific Symposium
59:41

What’s Next in Rare Disease Data Collection and Clinical Use - NORD Scientific Symposium

National Organization for Rare Disorders (NORD)
Attend the 2025 NORD Rare Diseases and Orphan Products Breakthrough Summit
01:12

Attend the 2025 NORD Rare Diseases and Orphan Products Breakthrough Summit

National Organization for Rare Disorders (NORD)
Nord logo.png
Meeting at the office
Opthamology Innovation Source logo.jpg
OIS has set the benchmark for excellence in eye care innovation by uniting pioneering startups, leading strategics, top investors, and renowned clinicians. More than a conference, OIS is a trusted community where ideas take root, partnerships are born, and the future of ophthalmology is shaped. With expertly curated programming, exclusive networking opportunities, and unmatched access to breakthrough technologies, OIS empowers industry leaders to make impactful decisions and build relationships that last.

OIS: Ophthalmology Innovation Source

OIS Pod Ep #422: Rolling Up Sleeves with David Esposito and Connie Chang

OIS: Ophthalmology Innovation Source
OIS Pod Ep #422: Rolling Up Sleeves with David Esposito and Connie Chang
OIS Pod Ep #422: Rolling Up Sleeves with David Esposito and Connie Chang
47:11

OIS Pod Ep #422: Rolling Up Sleeves with David Esposito and Connie Chang

OIS: Ophthalmology Innovation Source
Investor Strategy Understanding your investors and your investment strategies
36:18

Investor Strategy Understanding your investors and your investment strategies

OIS: Ophthalmology Innovation Source
Novaliq | Christian Roesky, PhD, CEO & Managing Director
07:28

Novaliq | Christian Roesky, PhD, CEO & Managing Director

OIS: Ophthalmology Innovation Source
Meeting at the office
Ocular Melanoma Foundation logo.jpeg
Ocular Melanoma Foundation banner 1.jpg

Ocular Melanoma Foundation is raising funds, engaging academicians and clinicians, and actively partnering with foundations and other leading agencies supporting cancer research to:
 

1.  Support and accelerate scientific research and discovery and its translation into effective treatment options for patients.

2.  Provide resources for education and support to OM patients, their families, and to healthcare professionals treating OM.

3.  Act as an advocate within the melanoma and broader cancer community to raise the awareness of OM and the need for a cure.

Ocular Melanoma Foundation

Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong

Ocular Melanoma Foundation
Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong
Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong
40:41

Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong

Ocular Melanoma Foundation
Overview of Melanoma Gene Expression Profile (GEP) Test by Castle Biosciences
36:28

Overview of Melanoma Gene Expression Profile (GEP) Test by Castle Biosciences

Ocular Melanoma Foundation
Patient Q&A with Ocular Melanoma Experts, Dr. Damato, Hovland, Mruthyunjaya, Seider
35:31

Patient Q&A with Ocular Melanoma Experts, Dr. Damato, Hovland, Mruthyunjaya, Seider

Ocular Melanoma Foundation
2017 Eye Am Not Alone
Patient & Caregiver Conference

Hosted by Ocular Melanoma Foundation

2017 OMF EANA Patient & Caregiver Conference

Experience Battling Ocular Melanoma as a Patient and a Mother

Ocular Melanoma Foundation
Experience Battling Ocular Melanoma as a Patient and a Mother
Experience Battling Ocular Melanoma as a Patient and a Mother
10:28

Experience Battling Ocular Melanoma as a Patient and a Mother

Ocular Melanoma Foundation
Clinical Trials for Ocular Melanoma, Discussion with Drs. Mruthyunjaya, Dr. Patel, and Dr. Stecher
54:36

Clinical Trials for Ocular Melanoma, Discussion with Drs. Mruthyunjaya, Dr. Patel, and Dr. Stecher

Ocular Melanoma Foundation
Overview of Uveal Melanoma, Dr. Prithvi Mruthyunjaya
35:18

Overview of Uveal Melanoma, Dr. Prithvi Mruthyunjaya

Ocular Melanoma Foundation
Meeting at the office
Rare Cancer Research Foundation profile.jpg
Empowering Patiets Rare Cancer Research Alliance banner.jpg
The Rare Cancer Alliance

Accelerating Cures Through

Patient-Powered Collaboration

MRA is the world’s largest private nonprofit funder of melanoma research.

We’ve directly invested over $175 million toward scientific discoveries,

and we won’t stop until we achieve our mission of curing melanoma.

Rare Cancer Research Foundation

Pattern.org Walkthrough

Rare Cancer Research Foundation
Pattern.org Walkthrough
Pattern.org Walkthrough
04:06

Pattern.org Walkthrough

Rare Cancer Research Foundation
Dr. Jesse Boehm Discusses Importance of Rare Cancer Tissue Donation Through Pattern.org
02:01

Dr. Jesse Boehm Discusses Importance of Rare Cancer Tissue Donation Through Pattern.org

Rare Cancer Research Foundation
Accelerating Cancer Research: An Overview of The Rare Cancer Research Foundation
01:29

Accelerating Cancer Research: An Overview of The Rare Cancer Research Foundation

Rare Cancer Research Foundation
Meeting at the office
ENTERTAINMENT. Beyond Mishawaka.

Meeting at the office
Ocular Cancer Logo2.png

Your Journey. Your Story. Your Strength. 

Our Mission:
The Ocular Cancer Team is dedicated to raising awareness, advancing education, and empowering individuals impacted by rare eye cancers. We strive to promote early detection, support patients and caregivers, and advocate for research and treatment innovations - so that no one faces ocular cancer alone.

 

Our Goal:

To offers vital information, support, and resources for rare eye cancers - including ocular melanoma, retinoblastoma, conjunctival melanoma, and intraocular lymphoma - all in one place to empower patients and raise awareness.

  • Facebook
  • YouTube
  • Instagram
  • TikTok
See the Light. Ocular Melanoma is Real | OcularCancer.com
BlueOMBlack.org Facebook Group
Ocular Cancer Logo2.png

Launched 07.10.2025

Baby Blue Light Green Eye Cancer Awareness Ribbon.png
bottom of page